Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases.

Bibic VC, Brust TB, Burton JM.

Mult Scler Relat Disord. 2018 Dec 20;28:125-128. doi: 10.1016/j.msard.2018.12.028. [Epub ahead of print]

PMID:
30593981
2.

Area postrema syndrome: A short history of a pearl in demyelinating diseases.

Camara-Lemarroy CR, Burton JM.

Mult Scler. 2018 Nov 22:1352458518813105. doi: 10.1177/1352458518813105. [Epub ahead of print]

PMID:
30463481
3.

Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis.

Burton JM, Traboulsee A.

Can J Neurol Sci. 2018 Sep;45(5):487-488. doi: 10.1017/cjn.2018.317. No abstract available.

PMID:
30234473
4.

Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?

Costello F, Burton JM.

Eye Brain. 2018 Jul 31;10:47-63. doi: 10.2147/EB.S139417. eCollection 2018. Review.

5.

Should Spinal MRI Be Routinely Performed in Patients With Clinically Isolated Optic Neuritis?

Meltzer E, Frohman EM, Costello FE, Burton JM, Frohman TC.

J Neuroophthalmol. 2018 Dec;38(4):502-510. doi: 10.1097/WNO.0000000000000685. No abstract available.

PMID:
30001224
6.

The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis.

Burton JM, Freedman MS.

J Neuroophthalmol. 2018 Jun;38(2):210-216. doi: 10.1097/WNO.0000000000000659.

PMID:
29750735
7.

Multiple Sclerosis: Eyes on the Future.

Costello FE, Burton JM.

J Neuroophthalmol. 2018 Mar;38(1):81-84. doi: 10.1097/WNO.0000000000000631. No abstract available.

PMID:
29438264
8.

The prevalence of anxiety and associated factors in persons with multiple sclerosis.

Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB.

Mult Scler Relat Disord. 2018 Jan;19:35-39. doi: 10.1016/j.msard.2017.11.003.

PMID:
29125968
9.

Spina Bifida Management.

Phillips LA, Burton JM, Evans SH.

Curr Probl Pediatr Adolesc Health Care. 2017 Jul;47(7):173-177. doi: 10.1016/j.cppeds.2017.06.007. Epub 2017 Jul 19. Review.

PMID:
28734746
10.

Refractory Longitudinally Extensive Transverse Myelitis Responsive to Cyclophosphamide.

Baxter LJ, Chen S, Couillard P, Scott JN, Doig CJ, Costello F, Girard LP, Klassen J, Burton JM.

Can J Neurol Sci. 2017 Nov;44(6):736-739. doi: 10.1017/cjn.2017.201. Epub 2017 Jul 20.

PMID:
28724464
11.

Hypertonia.

Evans SH, Cameron MW, Burton JM.

Curr Probl Pediatr Adolesc Health Care. 2017 Jul;47(7):161-166. doi: 10.1016/j.cppeds.2017.06.005. Epub 2017 Jul 15. Review.

PMID:
28716516
12.

Calming the Storm: Dysautonomia for the Pediatrician.

Burton JM, Morozova OM.

Curr Probl Pediatr Adolesc Health Care. 2017 Jul;47(7):145-150. doi: 10.1016/j.cppeds.2017.06.009. Epub 2017 Jul 15. Review.

PMID:
28716515
13.

Determinants and incidence of depression in multiple sclerosis: A prospective cohort study.

Berzins SA, Bulloch AG, Burton JM, Dobson KS, Fick GH, Patten SB.

J Psychosom Res. 2017 Aug;99:169-176. doi: 10.1016/j.jpsychores.2017.06.012. Epub 2017 Jun 15.

PMID:
28712424
14.

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Commentary.

Burton JM.

Mult Scler. 2017 Jul;23(8):1060-1062. doi: 10.1177/1352458517697831. Epub 2017 Feb 1. No abstract available.

PMID:
28326882
15.

The Utility of Magnetic Resonance Imaging in Assessing Patients With Pituitary Tumors Compressing the Anterior Visual Pathway.

Ryu WHA, Starreveld Y, Burton JM, Liu J, Costello F; PITNET Study Group.

J Neuroophthalmol. 2017 Sep;37(3):230-238. doi: 10.1097/WNO.0000000000000408. Review.

PMID:
27391942
16.

Response to "Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis" by Knippenberg et al.

Burton JM.

Mult Scler. 2017 Jan;23(1):129-130. doi: 10.1177/1352458516652951. Epub 2016 Jul 11. No abstract available.

PMID:
27301384
17.

A prospective cohort study of vitamin D in optic neuritis recovery.

Burton JM, Eliasziw M, Trufyn J, Tung C, Carter G, Costello F.

Mult Scler. 2017 Jan;23(1):82-93. doi: 10.1177/1352458516642315. Epub 2016 Jul 11.

PMID:
27037181
18.

Vitamin D in multiple sclerosis and central nervous system demyelinating disease--a review.

Burton JM, Costello FE.

J Neuroophthalmol. 2015 Jun;35(2):194-200. doi: 10.1097/WNO.0000000000000256. Review.

PMID:
25985434
19.

The temporal evolution of structural and functional measures after acute optic neuritis.

Costello F, Pan YI, Yeh EA, Hodge W, Burton JM, Kardon R.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1369-73. doi: 10.1136/jnnp-2014-309704. Epub 2015 Feb 10.

PMID:
25669747
20.

Validity of four screening scales for major depression in MS.

Patten SB, Burton JM, Fiest KM, Wiebe S, Bulloch AG, Koch M, Dobson KS, Metz LM, Maxwell CJ, Jetté N.

Mult Scler. 2015 Jul;21(8):1064-71. doi: 10.1177/1352458514559297. Epub 2015 Jan 12.

PMID:
25583846

Supplemental Content

Loading ...
Support Center